Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Feasibility Study of Medtronic OmniaSecure Model 3930M Defibrillation Lead Implantation Via the Middle Cardiac Vein in Patients With Tricuspid Valve Regurgitation: MCV3930 EFS

NCT07811609 is registered in ClinicalTrials.gov with Minneapolis Heart Institute Foundation as lead sponsor.

NCT NCT07811609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07811609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Feasibility Study of Medtronic OmniaSecure Model 3930M Defibrillation Lead Implantation Via the Middle Cardiac Vein in Patients With Tricuspid Valve Regurgitation: MCV3930 EFS
Lead sponsor
Minneapolis Heart Institute Foundation
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
January 31, 2028
Enrollment
5 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

defibrillator, tricuspid valve regurgitation